Atossa Therapeutics
ATOS
#10540
Rank
NZ$33.17 M
Marketcap
NZ$3.33
Share price
6.21%
Change (1 day)
142.98%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.44. In 2024 the company made an earnings per share (EPS) of NZ-$0.35 an increase over its 2023 EPS that were of NZ-$0.42.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4218.26%
2024NZ-$0.35-16.67%
2023NZ-$0.4214.29%
2022NZ-$0.3716.67%
2021NZ-$0.32-90.86%
2020NZ-$3.48-2.96%
2019NZ-$3.59-63.09%
2018NZ-$9.73-49.63%
2017NZ-$19.32-57.87%
2016NZ-$45.85-74.01%
2015NZ-$176.41-9.18%
2014NZ-$194.24-12.86%
2013NZ-$222.8970.73%
2012NZ-$130.5534.08%
2011NZ-$97.37263.47%
2010NZ-$26.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.45-3,594.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$16.22-3,768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$20.10-4,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.49 236.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.37-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA